Demographic, medical, and behavioral characteristics associated with over the counter non-steroidal anti-inflammatory drug use in a population-based cohort: results from the Multi-Ethnic Study of Atherosclerosis

被引:25
|
作者
Delaney, Joseph A. C. [1 ,2 ]
Biggs, Mary L. [2 ]
Kronmal, Richard A. [2 ]
Psaty, Bruce M. [3 ,4 ]
机构
[1] Univ Florida, Coll Pharm, Dept Pharmaceut Outcomes & Policy, HPNP, Gainesville, FL 32610 USA
[2] Univ Washington, Dept Biostat, Seattle, WA 98195 USA
[3] Univ Washington, Dept Med Epidemiol & Hlth Serv, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA
[4] Grp Hlth, Grp Hlth Res Inst, Seattle, WA USA
关键词
aspirin; over the counter drug use; ethnicity; Multi-Ethnic Study of Atherosclerosis; PRACTICE RESEARCH DATABASE; CARDIOVASCULAR HEALTH; MYOCARDIAL-INFARCTION; ASPIRIN; DISEASE; ADULTS; RISK; NONPRESCRIPTION; METAANALYSIS; ANALGESICS;
D O I
10.1002/pds.2065
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Three types of non-steroidal anti-inflammatory drugs (NSAIDs) can be obtained both over the counter (OTC) and by prescription in the United States. OTC NSAID use is not recorded in prescription claims databases; this might lead to differential misclassification of NSAID exposure status in studies that use computerized pharmacy databases to study NSAID use. Objective To evaluate characteristics of OTC versus prescription NSAID users. Methods This analysis is set within the Multi-Ethnic Study of Atherosclerosis (MESA) study; a prospective cohort study of 6814 adults from four ethnic groups (European descent, Asian, African-American, and Hispanic) with a mean age of 62 years. The cohort was restricted to those who initiated NSAID use (aspirin, ibuprofen, or naproxen) during follow-up. We compared information about age, sex, ethnicity, body mass index, smoking, diabetes, medication use, education, income, health insurance status, and exercise between groups. Results OTC NSAID use was prevalent at baseline (25% aspirin, 9% ibuprofen, and 2% naproxen). Compared to prescribed NSAID use, OTC NSAID use was lower for users of non-European descent for all classes: aspirin (p<0.0001), ibuprofen (p<0.0001), and naproxen (p = 0.0094). For aspirin, differences were seen for male gender (relative risk (RR): 0.92; 95% confidence interval (CI): 0.86-0.98), use of lipid lowering drugs (RR: 0.88; 95% CI: 0.80-0.96), low income (RR: 0.89; 95% CI: 0.81-0.97), and participants one standard deviation above average in intentional exercise (RR: 1.03; 95% CI: 1.01-1.05). Conclusions OTC NSAID use is prevalent in an older multi-ethnic population and OTC users differ from prescription NSAID users. Caution should be exercised when using prescribed NSAIDs as a proxy for NSAID use. Copyright (C) 2010 John Wiley & Sons, Ltd.
引用
收藏
页码:83 / 89
页数:7
相关论文
共 38 条
  • [1] Ethnic inequality in non-steroidal anti-inflammatory drug-associated harm in New Zealand: A national population-based cohort study
    Tomlin, Andrew
    Woods, David John
    Lambie, Angela
    Eskildsen, Lisa
    Ng, Jerome
    Tilyard, Murray
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 (08) : 881 - 889
  • [2] Non-steroidal anti-inflammatory medication use and endometrial cancer survival: A population-based Norwegian cohort study
    Haug, Ala Jabri
    Stoer, Nathalie
    Langseth, Hilde
    Siafarikas, Franziska
    Botteri, Edoardo
    Fortner, Renee Turzanski
    Lindemann, Kristina
    INTERNATIONAL JOURNAL OF CANCER, 2025,
  • [3] Maintenance use of non-steroidal anti-inflammatory drugs and risk of gastrointestinal cancer in a nationwide population-based cohort study in Sweden
    Brusselaers, Nele
    Lagergren, Jesper
    BMJ OPEN, 2018, 8 (07):
  • [4] High-risk use of over-the-counter non-steroidal anti-inflammatory drugs: a population-based cross-sectional study
    Koffeman, Aafke R.
    Valkhoff, Vera E.
    Celik, Sevde
    't Jong, Geert W.
    Sturkenboom, Miriam C. J. M.
    Bindels, Patrick J. E.
    van der Lei, Johan
    Luijsterburg, Pim A. J.
    Bierma-Zeinstra, Sita M. A.
    BRITISH JOURNAL OF GENERAL PRACTICE, 2014, 64 (621) : E191 - E198
  • [5] Non-steroidal anti-inflammatory drugs (NSAIDs) and hypertension treatment intensification: a population-based cohort study
    Fournier, Jean-Pascal
    Sommet, Agnes
    Bourrel, Robert
    Oustric, Stephane
    Pathak, Atul
    Lapeyre-Mestre, Maryse
    Montastruc, Jean-Louis
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 68 (11) : 1533 - 1540
  • [6] Impact of lifestyle and socioeconomic position on use of non-steroidal anti-inflammatory drugs: A population-based cohort study
    Bonnesen, Kasper
    Ehrenstein, Vera
    Gronkjaer, Marie S.
    Pedersen, Lars
    Lash, Timothy L.
    Schmidt, Morten
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 (04) : 455 - 467
  • [7] Associations between aspirin and other non-steroidal anti-inflammatory drugs and aortic valve or coronary artery calcification: The Multi-Ethnic Study of Atherosclerosis and the Heinz Nixdorf Recall Study
    Delaney, Joseph A.
    Lehmann, Nils
    Joeckel, Karl-Heinz
    Elmariah, Sammy
    Psaty, Bruce M.
    Mahabadi, Amir A.
    Budoff, Matt
    Kronmal, Richard A.
    Nasir, Khurram
    O'Brien, Kevin D.
    Moehlenkamp, Stefan
    Moebus, Susanne
    Dragano, Nico
    Winterstein, Almut G.
    Erbel, Raimund
    Kalsch, Hagen
    ATHEROSCLEROSIS, 2013, 229 (02) : 310 - 316
  • [8] Non-steroidal anti-inflammatory drug use does not appear to be associated with increased cardiovascular mortality in patients with inflammatory polyarthritis: results from a primary care based inception cohort of patients
    Goodson, N. J.
    Brookhart, A. M.
    Symmons, D. P. M.
    Silman, A. J.
    Solomon, D. H.
    ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (03) : 367 - 372
  • [9] Aspirin and other non-steroidal anti-inflammatory drug use and colorectal cancer survival: a cohort study
    Walker, A. J.
    Grainge, M. J.
    Card, T. R.
    BRITISH JOURNAL OF CANCER, 2012, 107 (09) : 1602 - 1607
  • [10] Aspirin and other non-steroidal anti-inflammatory drug use and colorectal cancer survival: a cohort study
    A J Walker
    M J Grainge
    T R Card
    British Journal of Cancer, 2012, 107 : 1602 - 1607